Rio de Janeiro is a state with close to 15 million inhabitants and approximately 250,000 births per year. The state counts nine clinical genetic units in public institutions, providing for 9,400 outpatient consultations yearly, which is insufficient to cover the estimated needs. Laboratory tests such as cytogenetics, inborn errors of metabolism and molecular studies are available on a limited basis. Newborn screening in the public health system is being performed for phenylketonuria, congenital hypothyroidism and sickle cell disease. In the state there are also special treatment programs for osteogenesis imperfecta and Gaucher’s disease, subsidized by the Brazilian Ministry of Health. Presently, efforts of medical geneticists are concentrated on highlighting the practical relevance of clinical genetics, and the need to integrate the specialty into the public health system in a functional network of genetic services.

Keywords:
Birth defects, Community genetics, Health policies, Medical services, Public health
1.
Horovitz D, Mattos R, Llerena J: Atenção aos defeitos congênitos no Brasil: propostas para estruturação e integração da abordagem no sistema de saúde; tese (Doutorado em Saúde Coletiva), Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, 2003.
2.
Marques-de-Faria AP, Ferraz VEF, Acosta AX, Brunoni D: Clinical genetics in developing countries: The case of Brazil. Community Genet 2004;7:95–105.
3.
Botler J: Programa ‘Primeiros Passos’ de Triagem Neonatal, pers commun, 2002.
4.
Fisher G: Serviço de referência em Triagem neonatal do Município do Rio de Janeiro – Hospital Municipal da Lagoa – SETRIN. Data on Rio de Janeiro county’s newborn screening program, pers commun, 2003.
5.
Lobo CL, Bueno LM, Moura P, Ogeda LL, Castilho D, Carvalho SM: Triagem neonatal para hemoglobinopatias no Rio de Janeiro, Brasil. Ver Panam Salud Publica 2003;13:154–159.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.